WallStreetZenWallStreetZen

NASDAQ: TECH
Bio Techne Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Bio Techne revenue was $1.20B for the trailing 12 months ending Dec 31, 2024, with -29.1% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $297.0M, up 2.6% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, TECH annual revenue was $1.2B, with 2% growth year-over-year.

TECH past revenue growth

How has TECH's revenue growth performed historically?

Company
4.46%
Industry
497.69%
Market
20.68%
TECH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TECH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TECH's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TECH revenue history

Current Revenue
$1.2B
Current Earnings
$158.1M
Current Profit Margin
13.2%
TECH's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when TECH announces revenue.

TECH Revenue History By Year

TECH Yearly RevenueTECH RevenueTECH ChangeTECH Revenue Growth
2024-06-30$1.16B$22.36M+1.97%
2023-06-30$1.14B$31.10M+2.81%
2022-06-30$1.11B$174.57M+18.75%
2021-06-30$931.03M$192.34M+26.04%
2020-06-30$738.69M$24.69M+3.46%
2019-06-30$714.01M$71.01M+11.04%
2018-06-30$642.99M$79.99M+14.21%
2017-06-30$563.00M$63.98M+12.82%
2016-06-30$499.02M$46.78M+10.34%
2015-06-30$452.25M$94.48M+26.41%
2014-06-30$357.76M$47.19M+15.19%
2013-06-30$310.58M-$3.99M-1.27%
2012-06-30$314.56M$24.60M+8.48%
2011-06-30$289.96M$20.92M+7.77%
2010-06-30$269.05M$5.09M+1.93%
2009-06-30$263.96M$6.54M+2.54%
2008-06-30$257.42M$33.94M+15.19%
2007-06-30$223.48M$20.87M+10.30%
2006-06-30$202.62M$23.97M+13.41%
2005-06-30$178.65M$17.40M+10.79%
2004-06-30$161.26M$16.25M+11.20%
2003-06-30$145.01M$14.11M+10.78%
2002-06-30$130.90M$15.54M+13.47%
2001-06-30$115.36M$11.52M+11.09%
2000-06-30$103.84M$12.94M+14.23%
1999-06-30$90.90M$23.61M+35.09%
1998-06-30$67.29M$6.37M+10.45%
1997-06-30$60.92M$6.33M+11.60%
1996-06-30$54.59M$6.87M+14.40%
1995-06-30$47.72MN/AN/A

1 of 2

Bio Techne Revenue FAQ

What was TECH's revenue last quarter?

On Invalid Date, Bio Techne (NASDAQ: TECH) reported Q4 2024 revenue of $297.03 million up 8.96% year over year. In the same quarter last year, Bio Techne's revenue was $272.60 million.

What was Bio Techne's revenue in 2024?

Bio Techne's annual revenue for the twelve months ending Jun 30, 2024 was $1.16 billion, a 1.97% increase year over year.

How much does Bio Techne make in a day?

Based on Bio Techne annual revenue for the past five years, TECH makes an average of $2,778,676.16 per day.

What was Bio Techne's annual revenue growth in the past year?

As of Q2 2025, Bio Techne's revenue has grown 4.46% year over year. This is 493.24 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Bio Techne's revenue in the past year totaled $1.20 billion.

How much does Bio Techne make in a year?

Bio Techne's revenue by year for the past five years is:
  • Bio Techne's revenue for the twelve months ending Jun 30, 2024 was $1.16 billion, a 1.97% increase year over year.
  • Bio Techne's annual revenue for Jun 30, 2023 was $1.14 billion, a 2.81% increase from 2022.
  • Bio Techne's annual revenue for 2022 was $1.11 billion, a 18.75% increase from 2021.
  • Bio Techne's annual revenue for 2021 was $931.03 million, a 26.04% increase from 2020.
  • Bio Techne's annual revenue for 2020 was $738.69 million, a 3.46% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.